Form 8-K - Current report:
SEC Accession No. 0000950170-25-048619
Filing Date
2025-04-01
Accepted
2025-04-01 16:40:08
Documents
16
Period of Report
2025-04-01
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hcwb-20250401.htm   iXBRL 8-K 63909
2 EX-3.1A hcwb-ex3_1a.htm EX-3.1A 15462
3 EX-3.1B hcwb-ex3_1b.htm EX-3.1B 2120
4 EX-99.1 hcwb-ex99_1.htm EX-99.1 16592
5 GRAPHIC img74935850_0.jpg GRAPHIC 156552
6 GRAPHIC img90053791_0.jpg GRAPHIC 137410
  Complete submission text file 0000950170-25-048619.txt   632849

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT hcwb-20250401.xsd EX-101.SCH 25811
18 EXTRACTED XBRL INSTANCE DOCUMENT hcwb-20250401_htm.xml XML 4881
Mailing Address 2929 N COMMERCE PKWY MIRAMAR FL 33025
Business Address 2929 N COMMERCE PKWY MIRAMAR FL 33025 954-842-2024
HCW Biologics Inc. (Filer) CIK: 0001828673 (see all company filings)

EIN.: 825024477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40591 | Film No.: 25800383
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)